What’s the future of aortic valve replacement?
Our panel of experts Matt Brady, Ros Lancaster, Professor Geoff Moggridge and Lin Bowker-Lonnecker share their insights from both an academic and commercial perspective, on the impact of a range of current and future innovation pressures on the exciting and growing medical device space of TAVR (Transcatheter Aortic Valve Replacement).
Partner & head of medical therapy
Insights for innovation consultant
Professor, University of Cambridge
Medical Device Engineer, Arete Medical Tecnologies
Please complete the 4 fields displayed below to watch the panel discussion in full.